Significantly higher transient elevations of aCL IgG, aCL IgM, and anti-β2GPI IgG were found at hospital discharge (compared with admission and follow-up) for patients who had COVID-19 pneumonia and thrombosis in their personal history when compared to those without previous thrombosis. This evidence concerns the gene ACLY and deep vein thrombosis.